Jennifer Elliott, Pharm.D., C.D.E., Sara Reece, Pharm.D., C.D.E., B.C.-A.D.M.
Diabetes mellitus, an epidemic in the U.S. and worldwide, impacts the lives of both many patients and caregivers. One of the largest barriers to insulin management is the administration of insulin requiring subcutaneous injections with syringes or pen needles.
Drug treatment — Insulin
What is the Role of Glucose Control in the Prevention of Cardiovascular Disease in Type 2 Diabetes? (pages 12-13)
Have we made progress over the last year in determining the role of glucose control in prevention of cardiovascular events in people with Type 2 diabetes? Does the presentation of the data from TECOS and ELIXA add anything to our knowledge of how to prevent CV events in people with Type 2 diabetes? Will the trials scheduled to complete later this year, EMPA-REG OUTCOME and LEADER, provide any new data that will change clinical practice?
Complications and comorbidities — Cardiovascular disease